ACUITY SPATIAL GENOMICS
DEAD

Serial Number

90806947

Owner

Acuity Spatial Genomics, Inc.

Attorney

Gail I. Nevius Abbas

Filing Date

Jul 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ACUITY SPATIAL GENOMICS Trademark

Serial Number: 90806947

ACUITY SPATIAL GENOMICS is a trademark filed by Acuity Spatial Genomics, Inc. on July 1, 2021. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Acuity Spatial Genomics, Inc. (10 trademarks)

112 Robin Hill Road
Santa Barbara, CA 93117

Entity Type: 03

Trademark Details

Filing Date

July 1, 2021

Registration Date

Not Registered

Published for Opposition

April 11, 2023

Goods & Services

computer hardware; downloadable computer software for performing genomic, transcriptomic, proteomic, or multiomic imaging and in situ analysis of biological samples for scientific or medical research; computer systems comprised of computer hardware and downloadable computer software for performing imaging and analysis of biological samples for scientific or medical research; laboratory equipment and scientific instruments, namely, non-medical imaging devices in the nature of microscopes, fluidics devices in the nature of proportioning pumps, valves, and fluid reservoirs for use with microscopes, microfluidics devices in the nature of proportioning pumps, valves, and fluid reservoirs for use with microscopes, biological sample preparation equipment in the nature of reagent cartridges for housing reagents, and biological sample processing equipment in the nature of cover slips for sample processing, all of the foregoing for performing genomic, transcriptomic, proteomic, or multiomic imaging and in situ analysis of biological samples for scientific or medical research; downloadable computer software for performing genomic, transcriptomic, proteomic, or multiomic imaging and multicellular, single-cell, and subcellular analysis of biological samples for scientific or medical research; laboratory equipment and scientific instruments, namely, non-medical imaging devices in the nature of microscopes, fluidics devices in the nature of proportioning pumps, valves, and fluid reservoirs for use with microscopes, microfluidics devices in the nature of proportioning pumps, valves, and fluid reservoirs for use with microscopes, biological sample preparation equipment in the nature of reagent cartridges for housing reagents, and biological sample processing equipment in the nature of cover slips for sample processing, all of the foregoing for performing genomic, transcriptomic, proteomic, or multiomic imaging and multicellular, single-cell, and subcellular analysis of biological samples for scientific or medical research

Biological and chemical reagents for scientific or medical research and kits consisting primarily of reagents for scientific or medical research comprised of oligonucleotides, probes, primers, antibodies, permeabilization solutions, denaturation solutions, fixation reagents, ligation solutions, biochemical buffers, hybridization solutions, imaging solutions, enzymes, fluorescent dyes, and microsphere beads for genomic, transcriptomic, proteomic, or multiomic in situ analysis of biological samples; Biological and chemical reagents for scientific or medical research and kits consisting primarily of reagents for scientific or medical research comprised of oligonucleotides, probes, primers, antibodies, permeabilization solutions, denaturation solutions, fixation reagents, ligation solutions, biochemical buffers, hybridization solutions, imaging solutions, enzymes, fluorescent dyes, and microsphere beads for genomic, transcriptomic, proteomic, or multiomic analysis of individual cells or multiple individual cells; Biological and chemical reagents for scientific or medical research and kits consisting primarily of reagents for scientific or medical research comprised of oligonucleotides, probes, primers, antibodies, permeabilization solutions, denaturation solutions, fixation reagents, ligation solutions, biochemical buffers, hybridization solutions, imaging solutions, enzymes, fluorescent dyes, and microsphere beads for genomic, transcriptomic, proteomic, or multiomic subcellular analysis of biological samples

scientific and medical research services for performing genomic, transcriptomic, proteomic, or multiomic in situ analysis of biological samples; scientific and medical research services for performing genomic, transcriptomic, proteomic, or multiomic single-cell or multicell analysis of biological samples; scientific and medical research services for performing genomic, transcriptomic, proteomic, or multiomic subcellular analysis of biological samples; providing online non-downloadable software for data storage, data management, data analysis, data interpretation, data visualization, and data reporting of genomic, transcriptomic, proteomic, or multiomic analysis of biological samples for scientific or medical research; Providing temporary use of non-downloadable cloud-based software for data storage, data management, data analysis, data interpretation, data visualization, and data reporting of genomic, transcriptomic, proteomic, or multiomic analysis of biological samples for scientific or medical research

Filing History

PETITION TO DIRECTOR DISMISSED
Feb 22, 2024 PC.D
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Feb 20, 2024 MAB4
OPPOSITION TERMINATED NO. 999999
Feb 20, 2024 OP.T
ABANDONMENT - AFTER INTER PARTES DECISION
Feb 20, 2024 ABN4
OPPOSITION SUSTAINED NO. 999999
Feb 20, 2024 OP.S
ASSIGNED TO PETITION STAFF
Feb 16, 2024 APET
TEAS PETITION TO DIRECTOR RECEIVED
Dec 18, 2023 TPDR
OPPOSITION INSTITUTED NO. 999999
Aug 9, 2023 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
May 10, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 15, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2021 NWOS
NEW APPLICATION ENTERED
Jul 5, 2021 NWAP